Exact Sciences Corporation (EXAS) Sharpe Ratio

Sharpe ratio is not yet available for EXAS. This metric requires at least 12 months of historical daily returns to calculate. Check back once this data is available.

How it compares to other similar stocks

The table compares Exact Sciences Corporation's Sharpe Ratio with other stocks in the Diagnostics & Research industry across multiple time periods, showing how EXAS's risk-adjusted performance compares to industry peers.

Data shows 1-, 5-, and 10-year periods, plus each stock's all-time average, as of Jun 5, 2026.

Symbol	Name	1Y Sharpe Ratio
CELC	Celcuity Inc.	3.72
GH	Guardant Health, Inc.	3.11
ILMN	Illumina, Inc.	2.19
TWST	Twist Bioscience Corporation	2.17
PRPO	Precipio, Inc.	1.65
BDSX	Biodesix, Inc.	1.57
BNR	Burning Rock Biotech Limited	1.55
PSNL	Personalis, Inc.	1.47
PRE	Prenetics Global Ltd	1.44
NEOG	Neogen Corporation	1.42
EXAS	Exact Sciences Corporation	—

Benchmark Against

Benchmark

S&P 500 Index

Lookback Period

How to choose period

Historical Sharpe Ratio

The chart shows EXAS's rolling Sharpe ratio over time compared to your chosen benchmark. Rising trends indicate improving returns relative to total volatility, while declining trends may signal deteriorating risk-adjusted performance or increased volatility. Use multiple timeframes to distinguish short-term fluctuations from long-term patterns.

Identify market cycles by observing when EXAS consistently outperforms (line above benchmark), underperforms (below benchmark), or aligns with the benchmark.

Loading charts...

Sharpe Ratio Calculator

How does EXAS fit in your portfolio?

Add your other holdings to see your portfolio's Sharpe Ratio and find out.

Analyze Your Portfolio